Meningiomas are tumors in the membranes that surround the brain and spinal cord. Most meningiomas are benign, but they may still cause serious problems as they grow and put pressure on other parts of your brain. At NewYork-Presbyterian, we develop an individualized plan of care that can range from "watchful waiting" to minimally invasive surgery. The choice of your treatment depends upon the characteristics of your meningioma, its location, and your symptoms. We offer you:

A Team of Specialists

We'll assemble the team of experts you need for your care. Together your team members will explore your options and reach a consensus about the best course of care for you.

Customized Treatment

If your meningioma isn’t causing any symptoms, we may simply watch it carefully. Other times, we may remove a meningioma using surgery. Some meningiomas respond best to radiation therapy alone, including highly precise stereotactic radiosurgery.

Exceptional Surgical Expertise

Using the latest and most detailed imaging techniques, we carefully plan your surgery and use the least invasive approach possible. Our highly skilled neurosurgeons perform state-of-the-art minimally invasive procedures.

Precision Radiation Therapy

Our neurosurgeons work closely with our radiation oncologists to explore all of your treatment options. If your meningioma is malignant, we may use precisely targeted beams of radiation after surgery designed to kill any remaining cancer cells. Some patients benefit from stereotactic radiosurgery, which involves the use of a highly focused beam of radiation to target tumor cells while leaving the surrounding brain tissue unaffected. It may be used instead of or in addition to surgery. Your doctor will let you know if radiation therapy is part of your treatment plan.

Chemotherapy When Needed

While generally not used to treat most meningiomas, chemotherapy may become part of your treatment if your tumor is malignant or comes back after surgery.

Clinical Trials

With two major academic medical centers — Columbia University Medical Center and Weill Cornell Medicine — we lead and participate in clinical trials of new therapies for meningiomas.